Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant

BACKGROUND: Ventricular assist devices(VAD) implantation/removal is a complex surgical procedure with perioperative bleeding complications occurring in nearly half of the cases. Recombinant activated factor VII (rFVIIa) has been used off-label to control severe hemorrhage in surgery and trauma. We r...

Descripción completa

Detalles Bibliográficos
Autores principales: Gandhi, Manish J, Pierce, Richard A, Zhang, Lini, Moon, Marc R, Despotis, George J, Moazami, Nader
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1939840/
https://www.ncbi.nlm.nih.gov/pubmed/17617902
http://dx.doi.org/10.1186/1749-8090-2-32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1939840/
https://www.ncbi.nlm.nih.gov/pubmed/17617902
http://dx.doi.org/10.1186/1749-8090-2-32

Ejemplares similares